Here are five insights:
1. Europe follows North America, capturing the second largest market share, because of medical technology advancements and increases in healthcare expenditure.
2. Asia will witness significant growth in the medical implants market, due to an aging population and a growing awareness of medical implant therapeutic applications.
3. India and China will lead growth within the Asian market.
4. High costs and unfavorable reimbursement policies will stunt market growth.
5. Key market players include Johnson & Johnson, Abbott Laboratories, Edwards Life-sciences, Orthofix, Novartis International, Sorin S.p.A, Boston Scientific, Smith & Nephew, Tornier and Stryker.
More articles on devices:
NuVasive sentiment falls to 1.17 in Q1: 5 notes
Bioventus files for $150M IPO: 5 points
United Orthopedic Corp. teams up with Dr. Freddy Achecar to offer TKR, THR to underserved in China: 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
